|
Read more ›› |
By: PR Newswire Association LLC. - 29 Apr 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 29 Apr 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 29 Apr 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
X4 Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Ocugen, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Asensus Surgical, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Oncotelic, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Aquestive Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Lexicon Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Gritstone bio, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Cullinan Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
FibroGen, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Atea Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Allarity Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Regeneron Pharmaceuticals Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Kraig Biocraft Laboratories, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Zevra Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Intellia Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Bioventus LLC |
|
|
Read more ›› |
By: GlobeNewswire - 29 Apr 2024
|
Related companies:
Cognition Therapeutics, Inc. |
|
|
|